Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

This study is being done to answer the following question: What are the supportive care needs of informal caregivers of people with Erdheim-Chester disease and other histiocytic diseases?

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Self-identified informal caregiver (family member or friend who provides unpaid support) for a patient with Erdheim-Chester Disease (or LCH, RDD, or JXG for the exploratory aim).

Proficiency to complete study assessments in English, evaluated at the time of consent.

Age 18 or over.

Disqualifiers

Participant unwilling to sign consent.

Participant unable to complete web-based assessments.

Trial population

A target sample of 120 ICs of patients with Erdheim-Chester Disease will be enrolled in this study. Additionally, a target sample of 50 ICs of patients with other histiocytic disorders will be enrolled.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • online surveys

    Behavioral

    Survey data about supportive care needs, mood, and the experience of IC's finding meaning and purpose in the caregiving experience.

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Caregivers of Patients1 intervention

Trial outcomes

Primary outcomes

1

Supportive Care Needs of informal caregivers

measured by the McGill Quality of Life in Life Threatening Illness - Family Carer Version (QLLTI-FC)

Time frame
3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.